⚖️Roadmap

2024 Q4

• Define the core application scenarios and technical positioning.

• Establish a core technical and health data expert team.

• Launch the official website and social media channels; initiate community preheating.

• Start the Pre-Seed fundraising round.

• Onboard early partners, validate MVP, and establish user base.

2025 Q1

• Complete the Pre-Seed fundraising round.

• Finalize the protocol draft and begin foundational technology development.

• Release the protocol's alpha version and begin internal testing.

• Integrate the first DApp, PulseX, to collect feedback.

• Analyze feedback to plan privacy and security measures.

2025 Q2

• Complete the Seed fundraising round.

• Release the first smart device, PulseX wristband.

• Open APIs and SDKs for developers, creating an integration-friendly ecosystem.

• Officially launch Protocol V1 and make it available to early users.

• Implement basic privacy and security mechanisms.

2025 Q3

• Initiate the Pre-A round and Public Auction.

• Launch AI-driven health monitoring modules.

• Strengthen data anonymization and privacy techniques.

• Deploy the economic model.

• Introduce more health monitoring and medical service DApps.

2025 Q4

• Complete the Pre-A round and Public Auction.

• Expand international market efforts with a focus on key regions.

• Ensure protocol compatibility with leading smart device brands.

• Introduce PULSE governance functionality for decentralized management and proposals.

2026 Q1

• Launch user incentive mechanisms to encourage data contributions and community building.

• Optimize smart contracts to improve efficiency and user experience.

• Onboard DApps focused on medical consultation, health finance, and related sectors.

• Expand to international markets with localized teams.

2026 Q2

• Collaborate with international standard organizations and industry associations to align health data standards.

• Optimize AI models for enhanced prediction accuracy across regions and languages.

• Deploy cross-chain interoperability solutions for seamless data and value transfers.

• Stabilize tokenomics through market buybacks and adjustments.

2026 Q3

• Strengthen partnerships with medical equipment manufacturers, insurance companies, and pharmaceutical leaders.

• Enhance privacy compliance and collaborate with regulatory agencies.

• Expand support for DeSci projects, accelerating drug research and precision medicine.

• Launch health ecosystem reports and indexes to increase transparency and trust.

2026 Q4

• Continuously improve the protocol based on community proposals and governance results.

• Expand AI functionalities to include emotion recognition and psychological health applications.

• Develop innovative health insurance and financing products, such as tokenized insurance.

• Establish a global reputation as the foundational infrastructure of the health data and scientific research ecosystem.